TABLE 1

Molecular properties of CNS and non-CNS drugs




mol. wt.

Class

pKaa

ClogD

PSA
Å2
CNS drugs
Buspirone 386 Basic 7.5 3.39 69.64
Caffeine 194 Neutral -0.08 61.82
Carbamazepine 236 Neutral 2.67 46.33
Carisoprodol 260 Neutral 2.15 90.65
Chlorpromazine 319 Basic 9.4 3.36 31.78
Citalopram 324 Basic 9.6 0.74 36.26
Clozapine 327 Basic 7.1 3.28 30.87
Cyclobenzaprine 275 Basic 9.2 4.42 3.24
Diazepam 285 Neutral 2.96 32.67
Ethosuximide 141 Neutral 1.13 46.17
Fluoxetine 309 Basic 10.1 1.83 21.26
Fluvoxamine 318 Basic 9.4 1.21 56.84
Haloperidol 376 Basic 8.3 2.57 40.54
Hydrocodone 299 Basic 8.5 1.20 38.77
Hydroxyzine 375 Basic 7.1 2.27 35.94
Lamotrigine 256 Neutral -0.19 90.71
Meprobamate 218 Neutral 0.70 104.6
Methylphenidate 233 Basic 10.6 -0.28 38.33
Metoclopramide 300 Basic 9.6 0.18 67.59
Midazolam 326 Neutral 3.69 30.18
Morphine 285 Basic 8.3 0.33 52.93
Nortriptyline 263 Basic 10.1 3.11 12.03
Paroxetine 329 Basic 10.3 1.19 39.72
Phenytoin 252 Acid 8.3 2.44 58.20
Propoxyphene 339 Basic 9.2 3.66 29.54
Risperidone 410 Basic 8.4 2.22 64.16
9-OH-Risperidone 426 Basic 7.9 0.91 84.39
Selegiline 187 Basic 7.5 2.55 3.24
Sertraline 306 Basic 9.5 2.74 12.03
Sulpiride 341 Basic 8.9 -1.12 110.1
Thiopental 242 Acid 7.8 2.84 90.29
Trazodone 372 Basic 7.2 1.60 45.78
Venlafaxine 307 Basic 9.3 2.49 32.70
Zolpidem 277 Basic 6.9 1.07 37.61
Range 141-426 6.9-10.6a -1.12-4.42 3.24-110.1
Mean 297 8.7a 1.86 48.44
Non-CNS drugs
Amiodarone 645 Basic 9.4 6.64 42.68
Loperamide 477 Basic 8.1 4.22 43.78
Loratadine 383 Neutral 6.23 42.43
Prazosin 383 Basic 7.0 -0.01 107.0
Prednisone 358 Neutral 1.56 91.67
Quinidine 324 Basic 9.3 1.58 45.59
Ritonavir 721 Neutral 4.94 202.3
Verapamil 455 Basic 9.0 3.28 63.95
Range 358-721 7.0-9.4 -0.01-6.64 42.43-202.3
Mean
468

8.5a
3.56
79.91
  • PSA, polar surface area; clogD, computed octanol/water partition coefficient.

  • a pKa range and average reported only for bases, where indicated.